Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03075163Phase 4Terminated
Phase 4, randomised trial (2 arms), sponsored by University of California, Davis. Primary endpoint: Change in Nausea Score. Started Oct 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03075163.